In this study the investigators aim to quantitate the extent of cervical and upper thoracic brown adipose tissue (BAT) activation in lean and obese humans via positron emission tomography-computed tomography (PET-CT) in response to the non-specific beta adrenergic receptor (AR) agonist ephedrine. The investigators hypothesise that this pharmacological adrenergic stimulus will result in activation of BAT in these participants, and that this activation will be reduced in obese patients. This study will provide important preliminary information with respect to allowing the investigators to progress with longer trials with specific beta 3 AR agonists.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
25
single oral dose, 1mg/kg body weight
single dose of 1 mg/kg body weight
Alfred Hospital Heart Centre
Prahran, Victoria, Australia
BAT activity via PET-CT
Time frame: Baseline and 3 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.